E.g., 14-04-2021
E.g., 14-04-2021
We have found 337 results.
View by: Grid List
Sort by: Relevancy Date
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Living In A Stock Picker’s Market

    When only one major factor affects equities, correlations rise. At such points, the name of the game is not to pick the best stocks, but to get the ebb and flow of that key factor right. At other times, multiple factors are in play and these affect different stocks differently; in such periods, picking winners is vital. For most of last year, the US market was macro-dominated as the Covid-induced economic collapse caused equity correlations to...

    2
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Webinar: Global Investment Roundtable, April 2021

    In the long years between the 2008-09 financial crash and the 2020 Covid crisis the US stock market massively outperformed equities in the rest of the world. In recent quarters, however, the US market has lost its edge. Yesterday, Louis, KX and Udith weighed the merits of ex-US equities versus US stocks in a post-pandemic world.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Living With The Next Covid Wave

    Global markets are looking ahead to a post-pandemic world, but Covid-19 is still very much with us. Globally, new infection rates have risen sharply since late February, reversing their earlier decline. In the last few weeks, the US has experienced an alarming uptick in infections. The European Union is struggling to contain its latest Covid wave, which in several major countries compares with November’s for severity. And across the developing...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Strategy Monthly: The Case For Ex-US Equities

    The US trade deficit cycle suggests the world is heading towards a protracted period of US dollar depreciation. With valuations outside the US relatively attractive, and deglobalization meaning ex-US equities will offer greater diversification benefits in future, investors should consider increasing their exposure to ex-US equities.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Costs Of Biden’s Spending Plan

    On Wednesday, Joe Biden unveiled an ambitious US$2trn program of public infrastructure investment, to be funded by corporate tax hikes. In a nutshell, the plan is a proposal to transfer wealth from the broad US market to sectors favored by the government. The sectors that benefit from this largesse stand to enjoy a multi-year boom, with the cost to be borne by the rest of the market. However, the extent of this cost should not be exaggerated....

    2
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Webinar: The Future Of The Great US Rotation

    Much has happened in the US in the last eight weeks. More than 80mn Americans have been vaccinated against Covid, Congress has passed a stimulus bill worth 9% of GDP, and the Fed has confirmed its determination to remain among the most peaceable of inflation doves. In response, 10-year US treasury yields have leapt, and the rotation from growth stocks to value has grown more violent even as the broad equity market has ascended new heights. In...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Short And Long For The US Dollar

    After ending 2020 amid heavily negative sentiment, the US dollar has confounded near-term bears by edging higher year-to-date. The DXY dollar index has gained 2.75%, clawing back just over a third of its -7.5% decline in 2020. Perhaps this should not be too surprising. First, by the end of 2020, the US dollar was no longer blatantly overvalued. Second, the DXY found support at 90, its low of early 2018. Third, the near-term outlook for nominal...

    2
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Strengthening Case For Value

    In the last two weeks, US value stocks have given up some of the outperformance relative to growth that they racked up over the previous five. So has value’s spurt of outperformance now run its course, leaving the S&P 500 value index’s 11pp of outperformance relative to growth since the beginning of February as just a counter-trend blip against a backdrop of more than a decade’s underperformance? Or are the relative gains in value since the...

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Let's Twist Again

    When they sit down on Wednesday, the members of the Federal Open Market Committee will face a couple of knotty questions. Should they attempt to do anything about rising bond yields? And if so, what?

    4
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Enduring Cognitive Dissonance

    As yields continue to test new highs, Jay Powell is set to deliver a speech today reasserting the Federal Reserve’s view that inflation can push above its 2% target due to base effects and pent-up demand without monetary tightening being needed. This could offer temporary relief to equity investors, but resulting uncertainty in the bond market is likely to ensure an unstable trading environment.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Changing Composition Of US Inflation

    Investors are all in a tizz about US inflation as the economy begins to normalize and the effect of a huge fiscal stimulus is factored into calculations. Inflation expectations are above the Federal Reserve’s target at 2.2% and energy base effects mean the personal consumption expenditure reading is sure to rise from December’s 1.3%. So far, market action has been focused in the bond market (see A Discussion On Treasury Yields) but equity...

    2
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Webinar: The Economic Impact Of A New Era

    Vaccines, fiscal stimulus and cheap money are working together to bolster the outlook for growth and inflation in the United States. The US is also under new leadership with new priorities. Our US team of analysts explained what this all means for the economy and asset markets.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    US Banks And The Steepening Curve

    The brightening of the US economic outlook and the steepening of the US yield curve over the last three months have been positive for the shares of US commercial banks. The prospect of a return to normal as vaccination quells the pandemic means banks are more willing to extend credit. According to the Federal Reserve’s January senior loan officer survey, far fewer banks are now tightening their lending standards. Experience suggests this will...

    5
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The US Turns A Corner

    It was not surprising that the US economy grew at a mere 4% quarter-on-quarter annualized in the final period of 2020, but there was a grim recognition that the next phase of the recovery will be hard fought. There are, however, reason to be optimistic.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Follow The Money

    After last spring’s lockdowns, the Federal Reserve undertook a huge liquidity response and the US government borrowed hand over fist to keep a range of economic actors afloat: US companies got forgivable loans, households received cash grants and the jobless were offered enhanced unemployment payments. Even after this splurge, the Treasury is still left with wheelbarrow-loads of cash. In the year ahead, how these record sums of money are...

    6
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    An Unfavorable Risk-Reward Bet

    Today sees the US vaccination program initiated, and investors are enthused that some kind of return to normal life is finally becoming visible. Nowhere has this “glass half full” view been stronger than in the US corporate credit market, as yield spreads for both investment-grade and high-yield bonds have broken new lows. These moves have occurred despite treasury yields creeping higher, and are starting to look overcooked.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Rising Yields And US Housing

    Investors are looking ahead to us economic growth picking up as vaccines are deployed and restrictions dialed back. With the Federal Reserve having anchored short rates near zero, this dynamic is causing a yield-curve steepening. The question is whether higher yields feed back into a still vulnerable US economy and choke off the recovery.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Georgia On My Mind

    In the four weeks since the US election, the S&P 500 has climbed 7.5%. The bulk of that run-up can be attributed to hopes for an early vaccine roll-out, but at least some is due to the perceived decline in US political risk, Yet although US electoral risk may have diminished, it has not disappeared, and may yet return to affect investor positioning in markets over the coming weeks.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    A Boost From US Restocking

    As the latest wave of US coronavirus infections continues to worsen, the probability of a modest contraction in fourth quarter GDP is rising. However, there are solid arguments for believing that the worst case scenario for 4Q remains no worse than a mild contraction in output.

    3
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Brake On US Growth

    Hopes for effective coronavirus vaccination programs in 2021 propelled both the S&P 500 and the Russell 2000 small cap index to record high, but on the ground in the US, accelerating infections and rising hospitalization rates prompted more state and local governments to order additional restrictions in a bid to slow the spread of the virus.

    0
Show me: results